等待开盘 11-18 09:30:00 美东时间
-4.120
-1.63%
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
Baird analyst David Manthey maintains Ferguson Enterprises (NYSE:FERG) with a Outperform and raises the price target from $288 to $300.
11-10 19:40
Ferguson Enterprises Inc. (NYSE:FERG) is in focus Monday after the company reported better-than-expected third-quarter results and raised its full-year revenue outlook. Ferguson reported adjusted earnings of $3.43 per share, exceeding the $3.30 analyst estimate. Sales rose 9.5% year over year to $9....
11-09 21:13
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
RBC Capital analyst Mike Dahl maintains Ferguson Enterprises (NYSE:FERG) with a Outperform and lowers the price target from $290 to $286.
10-07 21:57
Wolfe Research analyst Nigel Coe assumes Ferguson Enterprises (NYSE:FERG) with a Peer Perform rating.
09-15 19:18
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
On August 11, 2026, Ferguson Enterprises Inc. ("Ferguson") (NYSE:FERG) announced that it has priced a public offering (the "Notes Offering") of $700 million in aggregate principal amount of 4.800% senior unsecured notes due 2029 (the "2029 Notes") and $500 million in aggregate principal amount of 5....
08-12 04:56
Ferguson Enterprises Inc. (NYSE:FERG) on Monday reported better-than-expected second-quarter results and raised its full-year outlook. Ferguson reported adjusted earnings of $3.39 per share, topping the $3.29 analyst estimate. Sales rose 4.6% year over year to $8.75 billion, above the $8.67 billion ...
08-11 21:19
Baird analyst David Manthey maintains Ferguson Enterprises (NYSE:FERG) with a Outperform and raises the price target from $285 to $288.
08-11 19:38